558 related articles for article (PubMed ID: 23343957)
1. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy.
Das L; Blumbergs PC; Manavis J; Limaye VS
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):539-42. PubMed ID: 23343957
[TBL] [Abstract][Full Text] [Related]
2. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
Eymard B
Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
[TBL] [Abstract][Full Text] [Related]
3. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
[TBL] [Abstract][Full Text] [Related]
4. The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders.
Milisenda JC; Pinal-Fernandez I; Lloyd TE; Grau-Junyent JM; Christopher-Stine L; Corse AM; Mammen AL
Rheumatology (Oxford); 2023 Sep; 62(9):3156-3160. PubMed ID: 36707996
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies.
Englund P; Lindroos E; Nennesmo I; Klareskog L; Lundberg IE
Am J Pathol; 2001 Oct; 159(4):1263-73. PubMed ID: 11583954
[TBL] [Abstract][Full Text] [Related]
6. Major histocompatibility complex class I and II detection as a diagnostic tool in idiopathic inflammatory myopathies.
Jain A; Sharma MC; Sarkar C; Bhatia R; Singh S; Handa R
Arch Pathol Lab Med; 2007 Jul; 131(7):1070-6. PubMed ID: 17616993
[TBL] [Abstract][Full Text] [Related]
7. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.
De Paepe B; Creus KK; Martin JJ; Weis J; De Bleecker JL
Ann N Y Acad Sci; 2009 Sep; 1173():463-9. PubMed ID: 19758187
[TBL] [Abstract][Full Text] [Related]
8. Polymyositis: an overdiagnosed entity.
van der Meulen MF; Bronner IM; Hoogendijk JE; Burger H; van Venrooij WJ; Voskuyl AE; Dinant HJ; Linssen WH; Wokke JH; de Visser M
Neurology; 2003 Aug; 61(3):316-21. PubMed ID: 12913190
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
Choi YC; Dalakas MC
Neurology; 2000 Jan; 54(1):65-71. PubMed ID: 10636127
[TBL] [Abstract][Full Text] [Related]
10. [Idiopathic myositis].
Burgunder JM
Ther Umsch; 2003 Jul; 60(7):407-12. PubMed ID: 12956034
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility complex class I expression can be used as a diagnostic tool to differentiate idiopathic inflammatory myopathies from dystrophies.
Sundaram C; Uppin MS; Meena AK
Neurol India; 2008; 56(3):363-7. PubMed ID: 18974565
[TBL] [Abstract][Full Text] [Related]
12. Distal inflammatory myopathy: unusual presentation of polymyositis or new entity?
Dimitri D; Dubourg O; Maisonobe T; Fournier E; Ranque B; Laforêt P; Mussini JM; Pagnoux C; Béhin A; Papo T; Benveniste O; Eymard B; Herson S
Neuromuscul Disord; 2008 Jun; 18(6):493-500. PubMed ID: 18534849
[TBL] [Abstract][Full Text] [Related]
13. Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis.
Pinal-Fernandez I; Casal-Dominguez M; Derfoul A; Pak K; Miller FW; Milisenda JC; Grau-Junyent JM; Selva-O'Callaghan A; Carrion-Ribas C; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Corse AM; Mammen AL
Ann Rheum Dis; 2020 Sep; 79(9):1234-1242. PubMed ID: 32546599
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of inflammatory and autoimmune myopathies.
Dalakas MC
Presse Med; 2011 Apr; 40(4 Pt 2):e237-47. PubMed ID: 21411269
[TBL] [Abstract][Full Text] [Related]
15. MHC class I and II expression in juvenile dermatomyositis skeletal muscle.
Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Sachetti S; Lotufo S; Matsumura N; Marie SK
Clin Exp Rheumatol; 2009; 27(3):519-26. PubMed ID: 19604449
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
Gherardi RK
Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
[TBL] [Abstract][Full Text] [Related]
17. A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis.
Limaye VS; Lester S; Bardy P; Thompson P; Cox S; Blumbergs P; Roberts-Thomson P
Rheumatol Int; 2012 Mar; 32(3):611-9. PubMed ID: 21125283
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of FAS and FAS ligand in inflammatory myopathies.
De Bleecker JL; Meire VI; Van Walleghem IE; Groessens IM; Schröder JM
Acta Neuropathol; 2001 Jun; 101(6):572-8. PubMed ID: 11515785
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
Dourmishev LA
Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
[TBL] [Abstract][Full Text] [Related]
20. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE
Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
